Affiliation:
1. Department of Epidemiology Graduate School of Public Health University of Pittsburgh Pittsburgh Pennsylvania USA
2. Department of Neurology University of Pittsburgh Pittsburgh Pennsylvania USA
3. Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA
Subject
Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology
Reference25 articles.
1. Biogen. Aducanumab. (Combined FDA and Applicant PCNS Drugs Advisory Committee Briefing Document.https://fda.report/media/143503/PCNS-20201106-CombinedFDABiogenBackgrounder_0.pdf. Accessed November 20 2020.
2. Panel slams Alzheimer's drug;Servick K;Science,2020
3. PikeJ.Comment from Alzheimer's Association. Docket No. FDA‐2018‐N‐0410: Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments.https://beta.regulations.gov/document/FDA-2018-N-0410-0031. Accessed November 20 2020.
4. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
5. A resurrection of aducanumab for Alzheimer's disease
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献